Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06561321 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
A Phase 2 study of Palmoplantar Keratoderma, sponsored by Indiana University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT06561321: Recruiting Phase 2 study of Palmoplantar Keratoderma, sponsored by Indiana University.
NCT06561321 is a Phase 2 study of Palmoplantar Keratoderma that is actively recruiting participants, run by Indiana University. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06561321, a Phase 2 study of Palmoplantar Keratoderma, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess adults with palmoplantar keratoderma (thickening skin layer on palms and soles) who are treated with the study drug, tapinarof. This is a naturally occuring compound used for the treatment of psoriasis. This study is being done to find out how well and safe this drug is for stopping or treating keratoderma. This study aims to investigate the positive impacts of daily topical Tapinarof use in the improvement of Keratoderma. Clinical efficacy and safety profile of prescribing Tapinarof for this condition will be evaluated.
Conditions Studied
Interventions
- DRUG Tapinarof
Study Locations (1)
Indiana
- Indiana University Department of Dermatology - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-10-30 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06561321
The ClinicalTrials.gov registry entry for NCT06561321 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Palmoplantar Keratoderma appearing as the primary indexed condition, and to 1 intervention - of which Tapinarof is the first listed.
NCT06561321 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06561321 about?
NCT06561321 is a clinical study titled "Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma". The purpose of this study is to assess adults with palmoplantar keratoderma (thickening skin layer on palms and soles) who are treated with the study drug, tapinarof. This is a naturally occuring compound used for the treatment of psoriasis. This study is being done to find out how well and safe thi...
What is the current status of trial NCT06561321?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2024-10-30. Estimated completion is 2027-12-31.
What conditions does trial NCT06561321 study?
This clinical trial studies the following conditions: Palmoplantar Keratoderma.
What interventions are being tested in trial NCT06561321?
The interventions under investigation include: Tapinarof (DRUG).
Who is sponsoring clinical trial NCT06561321?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06561321 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.